Skip to main content
. 2021 Sep 27;102(2):605–652. doi: 10.1152/physrev.00005.2021

FIGURE 9.

FIGURE 9.

Ultimate success for antifibrotic drug development will be achieved by combining the pipelines for preclinical targets and the development of validated clinical trial end points with partnerships with industry to properly test novel compounds. IBD, inflammatory bowel disease.